JHU-083: 6-diazo-5-oxo-L-norleucine Precursor in Neuro Model
2026-07-07
JHU-083 delivers selective glutaminase inhibition for cutting-edge neurological and experimental cerebral malaria research, empowering precise manipulation of glutamate pathways in vivo. Its robust solubility and validated purity streamline redox and excitotoxicity studies, making it a cornerstone for translational workflows.
BV6 IAP Antagonist: Optimizing Apoptosis Induction Workflows
2026-07-06
BV6 is a selective IAP antagonist enabling precise modulation of apoptosis, radiosensitization, and disease modeling in cancer and endometriosis research. This guide translates experimental insights and troubleshooting strategies into actionable workflows, grounded in peer-reviewed mechanistic findings and APExBIO’s product reliability.
Sabutoclax: Pan-Bcl-2 Inhibitor Workflows in Cancer Research
2026-07-06
Sabutoclax stands out as a potent pan-Bcl-2 inhibitor, enabling robust, apoptosis-focused cancer research from in vitro screening to advanced xenograft models. This article details experimental workflows, troubleshooting tips, and applied innovations that maximize signal specificity and interpretability in apoptosis induction assays.
Bufalin: Applied Workflows in Triple-Negative Breast Cancer
2026-07-05
Bufalin, a cardiotonic steroid from APExBIO, is redefining cell-based cancer assays with its dual function as an apoptosis inducer and molecular glue degrader. This article delivers actionable protocols, troubleshooting insights, and evidence-backed innovations for researchers targeting aggressive cancers such as triple-negative breast cancer.
GTP Solution (100 mM): Enabling Precision in mRNA Therapeuti
2026-07-04
Explore how GTP Solution (100 mM) enhances the fidelity and efficiency of in vitro mRNA synthesis for advanced therapeutics. Discover unique insights into assay reliability and storage, with a focus on guanosine-5'-triphosphate's pivotal role in modern molecular biology.
Dacomitinib (PF-00299804): Mechanism and Applications in Can
2026-07-03
Dacomitinib (PF-00299804) is a potent irreversible pan-HER inhibitor, exhibiting strong efficacy against EGFR, HER2, and HER4-driven cancer models. It induces apoptosis and cell cycle G0–G1 arrest in resistant cancer cell lines. The compound's well-characterized mechanism supports its use in translational oncology workflows.
Nur77 Phase Separation Drives Apoptosis via Nur77/Bcl-2 Cond
2026-07-03
The referenced study identifies XS561 as a novel ligand that triggers apoptosis in tumor cells by promoting phase separation of Nur77 and the formation of Nur77/Bcl-2 mitochondrial condensates. This work reveals a mechanistic link between liquid–liquid phase separation and the activation of the caspase signaling pathway, underscoring new therapeutic avenues in drug-resistant breast cancers.
ML385: Advanced NRF2 Inhibitor Applications Beyond Oncology
2026-07-02
Discover how ML385, a selective NRF2 inhibitor, empowers research not only in cancer therapeutic resistance but also in oxidative stress and neuronal ferroptosis. This article delivers in-depth scientific insights and practical protocol guidance distinct from standard cancer-focused reviews.
EphA2 as a Synthetic Lethal Target in MYC-Driven TNBC
2026-07-02
This study establishes EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer (TNBC) using chemogenetic screening. The findings provide a new strategy for targeting aggressive MYC-activated cancers, independent of p53 status, and highlight the translational potential of pathway-specific targeting in oncology.
Pravastatin Sodium: Mechanistic Precision for Translational
2026-07-01
This thought-leadership article bridges the molecular mechanisms of Pravastatin sodium—a highly selective HMG-CoA reductase inhibitor—with strategic translational guidance. By examining cholesterol biosynthesis inhibition, LDL cholesterol reduction, and transporter interplay, it empowers researchers to design robust experiments and anticipate clinical translation hurdles. Drawing on recent hepatocyte studies, critical protocol parameters, and APExBIO’s product intelligence, this piece uniquely positions Pravastatin sodium within the evolving landscape of cardiovascular and metabolic research.
Saracatinib (AZD0530): Reliable Src/Abl Inhibition for Cell
2026-07-01
This article provides practical, scenario-based guidance for using Saracatinib (AZD0530), SKU A2133, in cell viability, proliferation, and migration assays. Bench scientists will find evidence-backed answers to common experimental challenges, workflow optimization tips, and candid vendor comparisons—anchored by APExBIO’s validated supply of Saracatinib (AZD0530).
FLAG tag Peptide (DYKDDDDK): Precision Tag for Protein Purif
2026-06-30
Unlock next-generation recombinant protein workflows with the FLAG tag Peptide (DYKDDDDK) from APExBIO. This guide delivers actionable protocols, advanced troubleshooting, and the latest reference-driven innovations for streamlined detection and purification in complex research settings.
Reelin-SFK Signaling Is Essential for Ketamine’s Antidepress
2026-06-30
This study establishes that intact synaptic Reelin signaling via Apoer2 and Src family kinases (SFKs) is a prerequisite for the synaptic plasticity and behavioral effects of ketamine in mouse models. Disruption of any component in this pathway abrogates ketamine’s efficacy, offering mechanistic insight into nonresponsiveness in treatment-resistant depression and opening new routes for translational research.
VX-661: Precision F508del CFTR Corrector for Cystic Fibrosis
2026-06-29
VX-661 (F508del CFTR corrector) empowers researchers to restore chloride channel function in cystic fibrosis models with robust, reproducible workflows. This guide translates the latest calnexin-dependent findings into actionable protocols and troubleshooting strategies for advanced CFTR modulation studies.
Recombinant Human FGF-19: Precision Tools for Metabolic and
2026-06-29
Explore the advanced scientific applications of Recombinant Human FGF-19 in metabolic and inflammatory research. This in-depth article highlights unique mechanistic insights and practical assay guidance to elevate your FGF-19 protein studies.
464 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page